RightEye secures FDA clearance for eye-tracking tech

Bethesda-based RightEye, an eye-tracking system for general healthcare and wellness, received clearance from the U.S. Food and Drug Administration (FDA) for its software that helps healthcare providers assess brain health, reading disorders and vision functionality.

This clearance will allow the healthtech company to use its cloud-based platform to record, view and analyze eye movements to help further identify visual tracking impairment in patients, according to a press release. Last year Technical.ly DC reported that RightEye nabbed a big investment from VSP Global Partners, allowing VSP’s network of 38,000 eye doctors use the RightEye platform for optometry exams.

“The RightEye system has been an asset to my practice for its ability to help identify conditions that may have otherwise gone unnoticed,” Adam Clarin, practicing optometrist at Clarin Eye Care in Miami, Fla., said in a statement. “The FDA clearance adds an extra layer of confidence for my patients and my practice.”

Since launching in 2012, RightEye has raised more than $10 million in venture capital, including the VSP investment. Through applications on a laptop, users can get vision trainings or engage in vision games that result in a report on their eye health. Though the RightEye devices can record, view and analyze eye movements, the company can not provide diagnoses.